Eya-Mist Rødgaard, BSc; Kristian Jensen, PhD; Jean-Noël Vergnes, PhD; et al.
open access
JAMA Psychiatry. 2019;76(11):1124-1132. doi:10.1001/jamapsychiatry.2019.1956
This meta-analysis assesses effect sizes for statistically significant group-level differences between individuals with autism and control individuals for 5 distinct psychological constructs and 2 neurologic markers.
Lasse Brandt, MD; Jonathan Henssler, MD; Martin Müller, MD; et al.
free access
has audio
JAMA Psychiatry. 2019;76(11):1133-1140. doi:10.1001/jamapsychiatry.2019.1937
This systematic review and meta-analysis evaluates the incidence of and vulnerability to nonaffectiveand affective psychoses among migrant groups in developed countries, using studies identified through PubMed, PsycINFO, and EMBASE.
-
Podcast:
Assessment of Psychosis Risk Among Refugees
Shihua Sun, MD; Ralf Kuja-Halkola, PhD; Stephen V. Faraone, PhD; et al.
free access
JAMA Psychiatry. 2019;76(11):1141-1149. doi:10.1001/jamapsychiatry.2019.1944
This cohort study investigates the association of psychiatric morbidity with all-cause and cause-specific mortality risks among children and adults with attention-deficit/hyperactivity disorder (ADHD) in Swedish national registers.
Georgina M. Hosang, PhD; Paul Lichtenstein, PhD; Angelica Ronald, PhD; et al.
open access
JAMA Psychiatry. 2019;76(11):1150-1158. doi:10.1001/jamapsychiatry.2019.1949
This twin study examines the degree to which genetic and environmental risk factors for attention-deficit/hyperactivity disorder (ADHD) traits, across childhood and adolescence, are associated with adolescent hypomanic symptoms.
Jeffrey F. Scherrer, PhD; Joanne Salas, MPH; Sonya B. Norman, PhD; et al.
free access
JAMA Psychiatry. 2019;76(11):1159-1166. doi:10.1001/jamapsychiatry.2019.2096
This cohort study examines whether clinically meaningful posttraumatic stress disorder symptom reduction is associated with lower risk of type 2 diabetes.
Frank Iorfino, PhD; Elizabeth M. Scott, MD, FRANZCP; Joanne S. Carpenter, PhD; et al.
free access
JAMA Psychiatry. 2019;76(11):1167-1175. doi:10.1001/jamapsychiatry.2019.2360
This Australian longitudinal cohort study follows up 2254 individuals aged 12 to 25 years who obtained care from early-intervention mental health services to compare progression of disorder based on demographic features and clinical stage at presentation.
Michael Amlung, PhD; Emma Marsden, BA; Katherine Holshausen, PhD; et al.
free access
JAMA Psychiatry. 2019;76(11):1176-1186. doi:10.1001/jamapsychiatry.2019.2102
This meta-analysis reviews articles from PubMed, MEDLINE, PsycInfo, Embase, and Web of Science to examine the role of delay discounting in individuals with psychiatric illness.
Holly K. Hamilton, PhD; Brian J. Roach, MS; Peter M. Bachman, PhD; et al.
free access
JAMA Psychiatry. 2019;76(11):1187-1197. doi:10.1001/jamapsychiatry.2019.2135
This case-control study evaluates the association of P300 event-related potential amplitude with clinical outcomes of youths with the psychosis risk syndrome.
Babak Hooshmand, MD, PhD, MPH; Helga Refsum, MD, PhD; A. David Smith, DPhil; et al.
free access
JAMA Psychiatry. 2019;76(11):1198-1205. doi:10.1001/jamapsychiatry.2019.1694
This cohort study examines whether methylation status is associated with incident dementia, Alzheimer disease, and structural brain changes in older adults.